{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:17:25Z","timestamp":1786540645961,"version":"build-2736575974"},"reference-count":89,"publisher":"National Institute for Health and Care Research","issue":"22","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["08\/53\/22"],"award-info":[{"award-number":["08\/53\/22"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Uterine fibroids are the most common tumour in women of reproductive age and are associated with heavy menstrual bleeding, abdominal discomfort, subfertility and reduced quality of life. For women wishing to retain their uterus and who do not respond to medical treatment, myomectomy and uterine artery embolisation are therapeutic options.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n We examined the clinical effectiveness and cost-effectiveness of uterine artery embolisation compared with myomectomy in the treatment of symptomatic fibroids.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A multicentre, open, randomised trial with a parallel economic evaluation.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Twenty-nine UK hospitals.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Premenopausal women who had symptomatic uterine fibroids amenable to myomectomy or uterine artery embolisation were recruited. Women were excluded if they had significant adenomyosis, any malignancy or pelvic inflammatory disease or if they had already had a previous open myomectomy or uterine artery embolisation.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomised to myomectomy or embolisation in a 1\u2009:\u20091 ratio using a minimisation algorithm. Myomectomy could be open abdominal, laparoscopic or hysteroscopic. Embolisation of the uterine arteries was performed under fluoroscopic guidance.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n The primary outcome was the Uterine Fibroid Symptom Quality of Life questionnaire (with scores ranging from 0 to 100 and a higher score indicating better quality of life) at 2 years, adjusted for baseline score. The economic evaluation estimated quality-adjusted life-years (derived from EuroQol-5 Dimensions, three-level version, and costs from the NHS perspective).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 254 women were randomised \u2013 127 to myomectomy (105 underwent myomectomy) and 127 to uterine artery embolisation (98 underwent embolisation). Information on the primary outcome at 2 years was available for 81% (n<\/jats:italic>\u2009=\u2009206) of women. Primary outcome scores at 2 years were 84.6 (standard deviation 21.5) in the myomectomy group and 80.0 (standard deviation 22.0) in the uterine artery embolisation group (intention-to-treat complete-case analysis mean adjusted difference 8.0, 95% confidence interval 1.8 to 14.1, p<\/jats:italic>\u2009=\u20090.01; mean adjusted difference using multiple imputation for missing responses 6.5, 95% confidence interval 1.1 to 11.9). The mean difference in the primary outcome at the 4-year follow-up time point was 5.0 (95% CI \u20131.4 to 11.5; p<\/jats:italic>\u2009=\u20090.13) in favour of myomectomy. Perioperative and postoperative complications from all initial procedures occurred in similar percentages of women in both groups (29% in the myomectomy group vs. 24% in the UAE group). Twelve women in the uterine embolisation group and six women in the myomectomy group reported pregnancies over 4 years, resulting in seven and five live births, respectively (hazard ratio 0.48, 95% confidence interval 0.18 to 1.28). Over a 2-year time horizon, uterine artery embolisation was associated with higher costs than myomectomy (mean cost \u00a37958, 95% confidence interval \u00a36304 to \u00a39612, vs. mean cost \u00a37314, 95% confidence interval \u00a35854 to \u00a38773), but with fewer quality-adjusted life-years gained (0.74, 95% confidence interval 0.70 to 0.78, vs. 0.83, 95% confidence interval 0.79 to 0.87). The differences in costs (difference \u00a3645, 95% confidence interval \u2013\u00a31381 to \u00a32580) and quality-adjusted life-years (difference \u20130.09, 95% confidence interval \u20130.11 to \u20130.04) were small. Similar results were observed over the 4-year time horizon. At a threshold of willingness to pay for a gain of 1 QALY of \u00a320,000, the probability of myomectomy being cost-effective is 98% at 2 years and 96% at 4 years.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n There were a substantial number of women who were not recruited because of their preference for a particular treatment option.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Among women with symptomatic uterine fibroids, myomectomy resulted in greater improvement in quality of life than did uterine artery embolisation. The differences in costs and quality-adjusted life-years are very small. Future research should involve women who are desiring pregnancy.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n This trial is registered as ISRCTN70772394.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This study was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme, and will be published in full in Health Technology Assessment<\/jats:italic>; Vol. 26, No. 22. See the NIHR Journals Library website for further project information.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/zdeg6110","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T09:02:25Z","timestamp":1650272545000},"page":"1-74","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT"],"prefix":"10.3310","volume":"26","clinical-trial-number":[{"clinical-trial-number":"isrctn70772394","registry":"10.18810\/isrctn","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3324-6771","authenticated-orcid":true,"given":"Jane","family":"Daniels","sequence":"first","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4621-1922","authenticated-orcid":true,"given":"Lee J","family":"Middleton","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-0913","authenticated-orcid":true,"given":"Versha","family":"Cheed","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-2932","authenticated-orcid":true,"given":"William","family":"McKinnon","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9133-3094","authenticated-orcid":true,"given":"Dikshyanta","family":"Rana","sequence":"additional","affiliation":[{"name":"Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8221-5763","authenticated-orcid":true,"given":"Fusun","family":"Sirkeci","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Whipps Cross Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3080-2357","authenticated-orcid":true,"given":"Isaac","family":"Manyonda","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, St George\u2019s Hospital and Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3703-9596","authenticated-orcid":true,"given":"Anna-Maria","family":"Belli","sequence":"additional","affiliation":[{"name":"Department of Radiology, St George\u2019s Hospital and Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2998-9185","authenticated-orcid":true,"given":"Mary Ann","family":"Lumsden","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-9174","authenticated-orcid":true,"given":"Jonathan","family":"Moss","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-6016","authenticated-orcid":true,"given":"Olivia","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-2569","authenticated-orcid":true,"given":"Klim","family":"McPherson","sequence":"additional","affiliation":[{"name":"Department of Primary Care, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2022,4]]},"reference":[{"key":"key20220411125113455_ref1-bib1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/1745-6215-15-468","article-title":"A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial","volume":"15","author":"McPherson","year":"2014","journal-title":"Trials"},{"key":"key20220411125113455_ref1-bib2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijgo.2015.04.051","article-title":"Prevalence, morbidity, and current medical management of uterine leiomyomas","volume":"131","author":"Drayer","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"key20220411125113455_ref1-bib3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20220411125113455_ref1-bib4","doi-asserted-by":"publisher","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"key20220411125113455_ref1-bib5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/humupd\/dmm013","article-title":"Fibroids and female reproduction: a critical analysis of the evidence","volume":"13","author":"Somigliana","year":"2007","journal-title":"Hum Reprod Update"},{"key":"key20220411125113455_ref1-bib6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","article-title":"Fibroids and infertility: an updated systematic review of the evidence","volume":"91","author":"Pritts","year":"2009","journal-title":"Fertil Steril"},{"key":"key20220411125113455_ref1-bib7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/AOG.0000000000002313","article-title":"Leiomyomas in pregnancy and spontaneous abortion: a systematic review and meta-analysis","volume":"130","author":"Sundermann","year":"2017","journal-title":"Obstet Gynecol"},{"key":"key20220411125113455_ref1-bib8","unstructured":"NHS Digital. Hospital Episode Statistics, Admitted Patient Care, England \u2013 2012\u20132013: Diagnosis. London: NHS Digital; 2013."},{"key":"key20220411125113455_ref1-bib9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"key20220411125113455_ref1-bib10","unstructured":"National Collaborating Centre for Women\u2019s and Children\u2019s Health. Heavy Menstrual Bleeding. Clinical Guideline CG044. London: Royal College of Obstetrics and Gynaecology Press; 2007."},{"key":"key20220411125113455_ref1-bib11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"key20220411125113455_ref1-bib12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","volume":"105","author":"Donnez","year":"2016","journal-title":"Fertil Steril"},{"key":"key20220411125113455_ref1-bib13","first-page":"11","article-title":"Ulipristal acetate (Esmya): restrictions on use","volume":"56","author":"DTB Team","year":"2018","journal-title":"Drug Ther Bull"},{"key":"key20220411125113455_ref1-bib14","doi-asserted-by":"publisher","first-page":"hoz027","DOI":"10.1093\/hropen\/hoz027","article-title":"A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids","volume":"2019","author":"Diamond","year":"2019","journal-title":"Hum Reprod Open"},{"key":"key20220411125113455_ref1-bib15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2174\/1381612826666200127092208","article-title":"Vilaprisan, a new selective progesterone receptor modulator in uterine fibroid pharmacotherapy-will it really be a breakthrough?","volume":"26","author":"Ciebiera","year":"2020","journal-title":"Curr Pharm Des"},{"key":"key20220411125113455_ref1-bib16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.maturitas.2012.09.006","article-title":"Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial","volume":"73","author":"LaCroix","year":"2012","journal-title":"Maturitas"},{"key":"key20220411125113455_ref1-bib17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1056\/NEJMoa1904351","article-title":"Elagolix for heavy menstrual bleeding in women with uterine fibroids","volume":"382","author":"Schlaff","year":"2020","journal-title":"N Engl J Med"},{"key":"key20220411125113455_ref1-bib18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.fertnstert.2019.07.013","article-title":"Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women","volume":"112","author":"Osuga","year":"2019","journal-title":"Fertil Steril"},{"key":"key20220411125113455_ref1-bib19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s43032-020-00172-z","article-title":"Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding-delayed add-back onset does not improve bleeding pattern","volume":"27","author":"Pohl","year":"2020","journal-title":"Reprod Sci"},{"key":"key20220411125113455_ref1-bib20","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/humrep\/dem105","article-title":"Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy","volume":"22","author":"Hehenkamp","year":"2007","journal-title":"Hum Reprod"},{"key":"key20220411125113455_ref1-bib21","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1471-0528.2010.02579.x","article-title":"The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids","volume":"117","author":"Rashid","year":"2010","journal-title":"BJOG"},{"key":"key20220411125113455_ref1-bib22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jvir.2012.12.002","article-title":"The impact of uterine artery embolization on ovarian function","volume":"24","author":"Kaump","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"key20220411125113455_ref1-bib23","unstructured":"National Institute for Health and Care Excellence (NICE). Magnetic Resonance Image-Guided Transcutaneous Focused Ultrasound for Uterine Fibroids. Interventional Procedures Guidance [IPG413]. London: NICE; 2011."},{"key":"key20220411125113455_ref1-bib24","doi-asserted-by":"publisher","first-page":"174.e1","DOI":"10.1016\/j.ajog.2018.10.032","article-title":"FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery","volume":"220","author":"Laughlin-Tommaso","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"key20220411125113455_ref1-bib25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/gyn.2019.0012","article-title":"Transcervical radiofrequency ablation of symptomatic uterine fibroids: 2-year results of the SONATA pivotal trial","volume":"35","author":"Miller","year":"2019","journal-title":"J Gynecol Surg"},{"key":"key20220411125113455_ref1-bib26","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2360107","article-title":"Percutaneous high frequency microwave ablation of uterine fibroids: systematic review","volume":"2018","author":"Ierardi","year":"2018","journal-title":"Biomed Res Int"},{"key":"key20220411125113455_ref1-bib27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejogrb.2005.10.008","article-title":"Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial","volume":"126","author":"Mara","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20220411125113455_ref1-bib28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00270-007-9195-2","article-title":"Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy","volume":"31","author":"Mara","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"key20220411125113455_ref1-bib29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00270-011-0228-5","article-title":"Uterine artery embolization versus myomectomy: impact on quality of life \u2013 results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial","volume":"35","author":"Manyonda","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"key20220411125113455_ref1-bib30","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/j.1471-0528.2011.02952.x","article-title":"Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results","volume":"118","author":"Moss","year":"2011","journal-title":"BJOG"},{"key":"key20220411125113455_ref1-bib31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00404-011-2065-9","article-title":"Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta-analysis of the literature","volume":"285","author":"Jun","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"key20220411125113455_ref1-bib32","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1007\/s00330-010-1829-0","article-title":"Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2-year follow-up results of a randomised prospective clinical trial","volume":"20","author":"Ruuskanen","year":"2010","journal-title":"Eur Radiol"},{"key":"key20220411125113455_ref1-bib33","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.ajog.2005.05.017","article-title":"Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial","volume":"193","author":"Hehenkamp","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key20220411125113455_ref1-bib34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1148\/radiol.2262011716","article-title":"Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment \u2013 a prospective, randomized, and controlled clinical trial","volume":"226","author":"Pinto","year":"2003","journal-title":"Radiology"},{"key":"key20220411125113455_ref1-bib35","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.clinthera.2017.05.346","article-title":"Uterine artery embolization and surgical methods for the treatment of symptomatic uterine leiomyomas: a systemic review and meta-analysis followed by indirect treatment comparison","volume":"39","author":"Fonseca","year":"2017","journal-title":"Clin Ther"},{"key":"key20220411125113455_ref1-bib36","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1007\/s00330-016-4681-z","article-title":"Fertility after uterine artery embolization for symptomatic multiple fibroids with no other infertility factors","volume":"27","author":"Torre","year":"2017","journal-title":"Eur Radiol"},{"key":"key20220411125113455_ref1-bib37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/aogs.13698","article-title":"The impact of uterine artery embolization on ovarian reserve: a systematic review and meta-analysis","volume":"99","author":"El Shamy","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key20220411125113455_ref1-bib38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.fertnstert.2007.11.078","article-title":"Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost\u2013utility analysis","volume":"91","author":"You","year":"2009","journal-title":"Fertil Steril"},{"key":"key20220411125113455_ref1-bib39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1471-0528.2007.01657.x","article-title":"Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids","volume":"115","author":"Zowall","year":"2008","journal-title":"BJOG"},{"key":"key20220411125113455_ref1-bib40","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/j.1471-0528.2007.01525.x","article-title":"Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study","volume":"114","author":"Wu","year":"2007","journal-title":"BJOG"},{"key":"key20220411125113455_ref1-bib41","first-page":"1","article-title":"Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) for treatment of symptomatic uterine fibroids: an economic analysis","volume":"15","author":"Babashov","year":"2015","journal-title":"Ont Health Technol Assess Ser"},{"key":"key20220411125113455_ref1-bib42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2217\/cer.14.32","article-title":"Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA","volume":"3","author":"Cain-Nielsen","year":"2014","journal-title":"J Comp Eff Res"},{"key":"key20220411125113455_ref1-bib43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1017\/S0266462309090035","article-title":"Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids","volume":"25","author":"O\u2019Sullivan","year":"2009","journal-title":"Int J Technol Assess Health Care"},{"key":"key20220411125113455_ref1-bib44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2214\/AJR.13.11446","article-title":"MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis","volume":"203","author":"Kong","year":"2014","journal-title":"Am J Roentgenol"},{"key":"key20220411125113455_ref1-bib45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1148\/radiol.2301021482","article-title":"Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids","volume":"230","author":"Beinfeld","year":"2004","journal-title":"Radiology"},{"key":"key20220411125113455_ref1-bib46","volume-title":"Uterine-Preserving Interventions for the Management of Symptomatic Uterine Fibroids: A Systematic Review of Clinical and Cost-Effectiveness","author":"Canadian Agency for Drugs and Technologies in Health","year":"2016"},{"key":"key20220411125113455_ref1-bib47","unstructured":"Royal College of Obstetricians and Gynaecologists, Royal College of Radiologists. Clinical Recommendations on the Use of Uterine Artery Embolisation in the Management of Fibroids. 2nd edn. London: Royal College of Obstetricians and Gynaecologists, Royal College of Radiologists; 2009."},{"key":"key20220411125113455_ref1-bib48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jmig.2011.09.005","article-title":"AAGL practice report: practice guidelines for the diagnosis and management of submucous leiomyomas","volume":"19","author":"American Association of Gynecologic Laparoscopists","year":"2012","journal-title":"J Minim Invasive Gynecol"},{"key":"key20220411125113455_ref1-bib49","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1016\/j.jacr.2018.03.010","article-title":"ACR Appropriateness Criteria\u00ae radiologic management of uterine leiomyomas","volume":"15","author":"Knuttinen","year":"2018","journal-title":"J Am Coll Radiol"},{"key":"key20220411125113455_ref1-bib50","volume-title":"Uterine Artery Embolisation for the Treatment of Uterine Fibroids","author":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists","year":"2020"},{"key":"key20220411125113455_ref1-bib51","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.fertnstert.2017.11.033","article-title":"Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis","volume":"109","author":"Sandberg","year":"2018","journal-title":"Fertil Steril"},{"key":"key20220411125113455_ref1-bib52","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.rbmo.2020.01.003","article-title":"Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids","volume":"40","author":"Khaw","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"key20220411125113455_ref1-bib53","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.fertnstert.2009.02.069","article-title":"Uterine artery embolization for fibroids is associated with an increased risk of miscarriage","volume":"94","author":"Homer","year":"2010","journal-title":"Fertil Steril"},{"key":"key20220411125113455_ref1-bib54","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0140-6736(05)17965-3","article-title":"A proposed charter for clinical trial data monitoring committees: helping them to do their job well","volume":"365","author":"DAMOCLES Study Group","year":"2005","journal-title":"Lancet"},{"key":"key20220411125113455_ref1-bib55","unstructured":"Great Britain. Mental Capacity Act 2005. London: The Stationery Office; 2005."},{"key":"key20220411125113455_ref1-bib56","unstructured":"Great Britain. Adults with Incapacity (Scotland) Act 2000. London: The Stationery Office; 2000."},{"key":"key20220411125113455_ref1-bib57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/00006250-200202000-00021","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"key20220411125113455_ref1-bib58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1477-7525-6-99","article-title":"The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL)","volume":"6","author":"Harding","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"key20220411125113455_ref1-bib59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jval.2011.07.007","article-title":"Further validation of the uterine fibroid symptom and quality-of-life questionnaire","volume":"15","author":"Coyne","year":"2012","journal-title":"Value Health"},{"key":"key20220411125113455_ref1-bib60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"The EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"key20220411125113455_ref1-bib61","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"key20220411125113455_ref1-bib62","volume-title":"Linear Mixed Models for Longitudinal Data","author":"Verbeke","year":"2000"},{"key":"key20220411125113455_ref1-bib63","doi-asserted-by":"crossref","DOI":"10.1002\/9781119013563","volume-title":"Statistical Analysis with Missing Data","author":"Little","year":"2002","edition":"2nd"},{"key":"key20220411125113455_ref1-bib64","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa1914735","article-title":"Uterine artery embolisation or myomectomy for uterine fibroids","volume":"383","author":"Manyonda","year":"2020","journal-title":"New Engl J Med"},{"key":"key20220411125113455_ref1-bib65","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.eurox.2021.100139","article-title":"Uterine artery embolization or myomectomy for women with uterine fibroids: four-year follow-up of a randomised controlled trial","volume":"13","author":"Daniels","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20220411125113455_ref1-bib66","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/1471-0528.16781","article-title":"Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost\u2013utility analysis of the FEMME trial","volume":"128","author":"Rana","year":"2021","journal-title":"BJOG"},{"key":"key20220411125113455_ref1-bib67","unstructured":"National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology Appraisal. London: NICE; 2013."},{"key":"key20220411125113455_ref1-bib68","volume-title":"Reference Costs 2017\u20132018","author":"Department of Health and Social Care","year":"2018"},{"key":"key20220411125113455_ref1-bib69","volume-title":"Unit Costs of Health and Social Care 2018.","author":"Curtis","year":"2018"},{"key":"key20220411125113455_ref1-bib70","volume-title":"British National Formulary","author":"The Royal Pharmaceutical Society","year":"2020"},{"key":"key20220411125113455_ref1-bib71","volume-title":"NHS Cost Inflation Index 2018\/19","year":"2019"},{"key":"key20220411125113455_ref1-bib72","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/hec.1785","article-title":"Spoilt for choice: implications of using alternative methods of costing hospital episode statistics","volume":"21","author":"Geue","year":"2012","journal-title":"Health Econ"},{"key":"key20220411125113455_ref1-bib73","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"key20220411125113455_ref1-bib74","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.944","article-title":"Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility","volume":"14","author":"Manca","year":"2005","journal-title":"Health Econ"},{"key":"key20220411125113455_ref1-bib75","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"PharmacoEconomics"},{"key":"key20220411125113455_ref1-bib76","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1524-4733.2005.00045.x","article-title":"Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report","volume":"8","author":"Ramsey","year":"2005","journal-title":"Value Health"},{"key":"key20220411125113455_ref1-bib77","volume-title":"Economic Evaluation in Clinical Trials","author":"Glick","year":"2007"},{"key":"key20220411125113455_ref1-bib78","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2011"},{"key":"key20220411125113455_ref1-bib79","volume-title":"Statistical Power Analysis for Behavioral Sciences: Revised","author":"Cohen","year":"1977"},{"key":"key20220411125113455_ref1-bib80","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","article-title":"Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D","volume":"14","author":"Walters","year":"2005","journal-title":"Qual Life Res"},{"key":"key20220411125113455_ref1-bib81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005073.pub2","article-title":"Uterine artery embolization for symptomatic uterine fibroids","volume":"1","author":"Gupta","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220411125113455_ref1-bib82","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jvir.2010.03.012","article-title":"Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison","volume":"21","author":"Narayan","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"key20220411125113455_ref1-bib83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.fertnstert.2005.05.074","article-title":"Uterine artery embolization versus myomectomy: a multicenter comparative study","volume":"85","author":"Goodwin","year":"2006","journal-title":"Fertil Steril"},{"key":"key20220411125113455_ref1-bib84","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s40273-018-0623-8","article-title":"Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries","volume":"36","author":"Janssen","year":"2018","journal-title":"PharmacoEconomics"},{"key":"key20220411125113455_ref1-bib85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005355.pub5","article-title":"Interventions to reduce haemorrhage during myomectomy for fibroids","volume":"8","author":"Kongnyuy","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220411125113455_ref1-bib86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013352.pub2","article-title":"In-bag manual versus uncontained power morcellation for laparoscopic myomectomy","volume":"5","author":"Zullo","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220411125113455_ref1-bib87","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s42155-018-0044-y","article-title":"Randomised trial of two embolic agents for uterine artery embolisation for fibroids: gelfoam versus embospheres (RAGE trial)","volume":"2","author":"Yadavali","year":"2019","journal-title":"CVIR Endovasc"},{"key":"key20220411125113455_ref1-bib88","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00270-013-0790-0","article-title":"Comparison of embolic agents used in uterine artery embolisation: a systematic review and meta-analysis","volume":"37","author":"Das","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"key20220411125113455_ref1-bib89","volume-title":"CoreUF: Developing a Core Outcome Set for Symptomatic Uterine Fibroids","author":"COMET Initiative","year":"2020"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2039428","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/ZDEG6110\/ZDEG6110.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2039428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:39:43Z","timestamp":1692113983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/ZDEG6110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":89,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["10.3310\/ZDEG6110"],"URL":"https:\/\/doi.org\/10.3310\/zdeg6110","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"6-2011","name":"contractual_start_date","label":"Contractual start date","group":{"name":"article_history","label":"Article History"}},{"value":"6-2020","name":"editorial_review_begun","label":"Editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"8-2021","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}